Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

Pear Therapeutics Announces Availability of reSET® and reSET-O® to Wellpath Community Care Center Patients; Wellpath to Bring Prescription Digital Therapeutics For Addiction to New Outpatient Treatment Centers
Read Me

Pear Therapeutics and PreferredOne Announce Broad Based Patient Access and Reimbursement for reSET® and reSET-O® for People with Substance Use Disorder and Opioid Use Disorder
Read Me

Aprea Therapeutics Promotes Gregory S. Wessels to Chief Commercial Officer and Announces Governance Changes
Read Me

Cidara Therapeutics to Present New Clinical and Preclinical Data for Rezafungin and Influenza AVCS at IDWeek 2020
Read Me

Escient Pharmaceuticals Raises $77.5 Million Series B Round and Initiates a Phase I/Ib Clinical Trial of EP547, a MRGPR-Targeted Therapy to Treat Cholestatic and Uremic Pruritus

Pushing the healthcare industry forward

$ 0 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $350M from 5AM Ventures VI and $147M from 5AM Opportunities I.
0

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
0

ONGOING CLINICAL TRIALS

Our portfolio companies currently have over 18,000 patients enrolled across 750 test sites in ongoing clinical trials.

San Francisco, CA

Boston, MA

San Francisco

501 Second Street
Suite 350
San Francisco, CA 94107

Tel: 415-993-8570
Boston

200 Clarendon Street
45th Floor
Boston, MA 02116

Tel: 857-305-1825

© 2020 5AM Venture Management LLC